Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Varicella Zoster Infection Treatment Market Snapshot

[276 Pages Report] The global Varicella Zoster Infection Treatment Market in 2020 is estimated for more than US$ 1.5 Bn and expected to reach a value of US$ 2.0 Bn by 2028 with a significant CAGR of 4.1%. As per Future Market Insights’ projections, in 2022, the acyclovir holds a substantial share of over 55.7% in the overall varicella zoster infection treatment market.

Human alphaherpesvirus 3, also known as Varicella Zoster virus (VZV) is one of the many herpesviruses that is known to infect humans. It is also the one causing infectious diseases like chicken pox (which is mostly common among children and teens) and herpes zoster (shingles) (mostly affecting adults but rarely in children). The growing incidence of herpes zoster (shingles) infection among the children’s and the elderly and the rising demand towards the treatment of the infection is aiding the growth of the market.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 1.61 billion
Market Value 2028 US$ 2.05 billion
CAGR 2022-2028 4.1%
Share of top 5 Countries 52.3%
Key Players Novartis AG; Pfizer Inc.; Abbott Laboratories; Sun Pharmaceuticals Industries Ltd.; Valeant Pharmaceuticals International Inc.; Teva Pharmaceutical Industries Ltd.; Dr. Reddy’s Laboratories, ltd.; Mylan N.V. and GlaxoSmithKline plc and Others (100% Market Share)

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 4.17%
H1, 2022 Projected 4.11%
H1, 2022 Outlook 4.01%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 16 ↓

A comparative analysis about the market growth rates and development prospects in the global varicella zoster infection treatment market have been mapped by Future Market Insights. According to the FMI analysis, compared to H1-2021, the market is expected to decline by 16 Basis Point Share (BPS) in H1 2022 (O).

Major reasons for this dip in BPS are attributed to the adverse effects of antiviral therapy which include neurological, gastrointestinal, and renal toxicity. The market further observes a decline in 10 BPS in H1-2022 outlook as compared to H1-2022 projected period.

The market is subject to be influenced by regulatory guidelines and medical device approvals in accordance with impact of macro, economic, and industry factors. Prevention of varicella zoster infection through vaccination strategies permits the avoidance of primary infections in neonates and vulnerable cases. These are some of the significant breakthroughs in the varicella zoster infection treatment market.

Other market segments are correspondingly set to perform objectively and attain promising growth prospects in the next half of projection period. Additionally, there are some factors which positively drive the industry growth, including the improvement of cell medicated immunity after second administration of varicella vaccine, and long-lasting immunity response of live attenuated vaccines.

2016-2021 Varicella Zoster Infection Treatment Demand Outlook Compared to 2022-2028 Forecast

The Global varicella zoster infection treatment market is expected to grow at a modest rate during the forecast period. The epidemiology of the varicella infection is higher in children aged 4-10 year. However, Herpes zoster occur due to reactivation of varicella zoster virus in older age, where, the incidence is higher in older age population >60 years compared to adults and children.

For instance, in 2021, United States (US) reported that the risk of Herpes Zoster increases with age. A cumulative incidence of Herpes Zoster were reported to be from 2.9–19.5 cases per 1,000 population and an incidence rate of Herpes Zoster ranging from 5.23–10.9 cases per 1,000 person-years. It is been expected that the incidence of herpes zoster in these countries will increase with increasing older age population.

Varicella Zoster Infection Treatment Market

The Global Varicella Zoster Infection Treatment market constitutes nearly 3% of the ~52.7 Bn Antiviral Drugs Market, globally in 2021. Herpes zoster is not common in children younger than 1 year and is rarely found in children’ younger than 1 year. However, if a pregnant female witness’s varicella zoster infection during pregnancy, there are high chances of the fetus developing asymptomatic congenital infections. Such children generally present herpes zoster within the first year of their life. Furthermore, the growing risk of prenatal varicella zoster leads to the uptake of antiviral drugs treatment later in pregnancy. Thus, the growing risk of postnatal varicella zoster infection in children younger than 1 year of age and the subsequent use of acyclovir as the first line of treatment for these infected children will drive the growth of varicella zoster infection treatment market in future.

Hence, the demand outlook for varicella zoster infection treatment market is expected to grow rapidly during the forecast period from 2022- 2028 owing to the growing demand for effective drug treatments for varicella zoster infections.

The market is expected to expand at a considerable growth rate for the period 2022-2028 at a CAGR of approximately 4.1%, and observe an incremental $ opportunity of USD 438.6 Mn from 2022 to 2028. Demand for Acyclovir drug as a first line treatment will remain the maximum throughout the forecast period.

What are the Key Opportunities for Market Players?

The increasing incidences of viral borne disease among children and old population, high transmission rate of the infection, high occurrence of infections in low or middle-income countries and growing revenue of the market players are the major factors contributing to the growth of the varicella zoster infection treatment market.

The companies in the varicella zoster infection treatment market are focusing on organic and inorganic growth by launching their products and to gain maximum market share.  Moreover, acquisitions, expansion of product portfolio and research & development capabilities are expected to create opportunities for the growth of the market.

  • For instance, in July 2021, US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to immunodeficiency or immunosuppression.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the key challenges to Varicella Zoster Infection Treatment Market?

The adverse effect of anti-viral therapy treatment among the elderly population presents a biggest challenge for the market to grow ahead, the elderly care itself is an intensive care segment and onset of viral diseases like Herpes Zoster increases the risk of associated infections and other reactions.

Moreover, availability of other treatment options for treating the herpes zoster and varicella such as homeopathy, supplements and other natural herbal medicines may also come out as a bigger challenge for the varicella zoster infection treatment market. A clinical study done in China also revealed that the modified Gentiana formula when combined with the topical cream as a treatment for post-herpetic neuralgia, was more effective than the antiviral drugs treatment. Additionally, introduction of generic drugs by the local players in large number together with rising cases of product recalls of many such drugs are leading to create quality concern of these generic drugs amongst the consumers. All such factors together may pose greater challenges for the varicella zoster infection treatment market growth during the forecast period.

What is the Impact of the COVID-19 Crisis on the Market?

The COVID-19 outbreak initially affected the market negatively due to the lockdowns that were imposed in the first half of 2020, which resulted in disruption of the supply chain. Also, fall in number of surgeries and reduced patient visits to the hospitals due to change in healthcare priorities and also as a prevention measure to avoid contracting the disease also resulted in drop in the number of patients visiting hospitals for disease other than COVID-19.

However, with the opening of all the economies and the people now adapting to the new normal the market is been expected to achieve significant growth during the forecast period. Companies are revising their long-term strategies to develop adequate crisis-management strategies that place a premium on next-generation products and solutions, varicella zoster

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Will the U.S. Remain a Key Market for Varicella Zoster Infection Market?

The U.S. is the leading country of the North American region with a total market value share of 90.3% in 2021 and is projected to continue commanding the high growth during the coming years from 2022- 2028. The deep incidence of herpes infection among children mainly drives the growth of this market & their humanization and increasing pets disorder owing to rise in disease incidence.

For instance, as per Centre for Diseases Prevention and Control, an estimated one million cases of herpes zoster occur annually in the United States. The incidence for herpes zoster is approximately 4 cases per 1,000 U.S. population annually.

Additionally, presence of major players involved in the commercialization and development of herpes zoster interventions is also one of the major factor for the growth of this market in this region.

Why is Germany Considered a More Lucrative Market within Europe?

Germany dominates the Western Europe market of varicella zoster, with a share of nearly 24.7% of the market share by value in 2021. Similar growth is expected throughout the forecast period owing to the higher prevalence of herpes and increasing research and development activities which is also contributing to the varicella zoster infection treatment market growth in the region.  

For instance, the incidence of HZ in Germany ranges from about 1/1,000 in children aged less than 10 years, to more than 10/1,000 in persons aged 80 years and older; the incidence becomes distinctly higher in persons from 50 years onwards.

Why is Japan an Emerging Market for Varicella zoster infection treatment?

In 2021, Japan holds around 6.9% share in the global market by value and is been estimated to expand at a CAGR of 2.7% during the forecast period. The rising incidence of Herpes Zoster in the general population aged ≥ 50 or ≥ 60 years in the country leads to enhance the demand of varicella zoster infection treatment.

Additionally, rising government funding and support for vaccination and awareness campaigns are expected to propel the varicella zoster infection treatment market forward throughout the projection period.

What is the Outlook in China for the Varicella Zoster Infection Treatment Market?

In 2021, China has considerable share by value in the global market ranging around 8.7% and is been projected to expand at a CAGR of 4.5% from 2022-2028. This is predominantly due to the increasing risk of herpes zoster among the elderly population. Approximately, 32% of the Chinese population is aged 50 years and older and this proportion is increasing. Because of the ageing population, the public burden associated with shingles is been expected to increase over the time.

Category-wise Insights

Which Varicella Zoster Infection Treatment Product is driving the market growth?

By product, acyclovir drug accounts for the highest share of around 55.9% in 2021 and expected to expand at a CAGR of 3.7% during the forecast period from 2022 - 2028. 

Acyclovir presents the broader scope for the treatment of herpes zoster. It is also used to treat repeat outbreaks to prevent further outbreaks of genital herpes (a herpes virus infection that causes sores to form around the genitals and rectum from time to time) in people with a normal immune system. Famciclovir is also used to treat returning herpes simplex infections of the skin and mucus membranes (mouth, anus) in people with human immunodeficiency virus (HIV) infection

Owing to its broader benefits, the varicella zoster infection treatment market is experiencing its faster adoption, resulting in driving the demand for the drug in the varicella zoster infection treatment during the forecast period from 2022-2028.

Why does the Oral route of drug administration hold a High Market Share?

The Oral route for drug administration dominates the varicella zoster infection treatment market, with a 64.3% of the revenue share in 2021. This trend is expected to continue to grow during the study period. The high share of this segment is been attributed to its inherited safety, higher absorption and increased usage in the procedures and related treatment.

Which Distribution Channel is leading the Global Varicella Zoster Infection Treatment Market?

Based on the distribution channel, hospital pharmacies is the leading segment, with 43% market share in 2021 and expanding at a CAGR of 3.9% in the forecast period. Growing number of herpes zoster treatments in the hospitals and availability of medicines in the hospital pharmacies, as these medicines can only be bought if prescribed by a doctor or medical practitioner, will provide lucrative opportunities for varicella zoster infection treatment market growth.

Competitive Landscape

The key companies are focusing on regulatory approvals, new drug launches and marketing of their brands to get more attention and gain maximum market share. Additionally, acquisitions, mergers and strategic collaborations play a vital role in the growth of the varicella zoster infection treatment market.

  • For Instance: In April 2017, Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. FDA for Acyclovir Ointment USP, 5%  is the first generic version of Valeant International's Zovirax Ointment
  • In December 2016, Slayback and Sandoz signed an agreement for the sale and marketing rights of Slayback Generic Zovirax Ointment (Acyclovir Ointment). Due to the agreement, Novartis got the sale and marketing rights, which augmented their position in the market.

In Dec 2015, Valeant Pharmaceuticals International, Inc. announced new fulfillment agreements with Walgreens. Due to these agreements, the company forayed into retail business pharmacies

Scope of the Report

Attribute Details
Forecast Period 2022 to 2028
Historical Data Available for 2012 to 2021
Market Analysis USD Million for Value, Units for Volume
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Benelux, Russia, China, Japan, India, ASEAN, Australia, New Zealand, and GCC Countries
Key Segments Covered Drug Type, Route of Administration, Distribution Channel, and Region
Key Companies Profiled Novartis AG; Pfizer Inc.; Abbott Laboratories; Sun Pharmaceuticals Industries Ltd.; Valeant Pharmaceuticals International Inc.; Teva Pharmaceutical Industries Ltd.; Dr. Reddy’s Laboratories, ltd.; Mylan N.V. and; GlaxoSmithKline
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Varicella Zoster Infection Treatment - Market Segmentation - by Category

By Drug Type:

  • Acyclovir
  • Valacyclovir
  • Famciclovir

By Route of Administration:

  • Oral
  • Injectable
  • Topical

By Distribution Channel:

  • Hospital pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • China
  • Japan
  • Middle East Africa

Frequently Asked Questions

How much is the market for Varicella Zoster Infection Treatment worth?

The varicella zoster infection treatment based market is worth at US$ 1.54 Bn in the year 2021 and is been expected to reach US$ 2.04 Bn by 2028

What is the demand outlook of the Varicella Zoster Infection Treatment Market?

Acyclovir drug is been projected to reflect high demand in the forecast period with a CAGR of 3.7%.

What are the key trends of Varicella zoster?

Increasing cases of herpes zoster in developed and developing countries, growing focus on clinical development of antiviral drugs, concerting efforts in mitigating the economic burden of varicella zoster virus Infection and growing adoption of effective anti-viral drug treatment are some of the trends that will fuel the demand for Varicella zoster.

What is the market share of the top countries in the Varicella Zoster Infection Treatment market?

The cumulative market share of the top countries constitutes nearly 52.3% of the overall global market share.

What are the top 5 countries driving demand for Varicella zoster?

U.S., China, Japan, Germany, and UK are the top 5 countries which are driving the demand for Varicella zoster.

At what rate is the sales of Varicella Zoster Infection Treatment rising in Western Europe?

Western Europe’s market is forecasted to grow at a CAGR of 3.6% between 2022- 2028. Germany being dominant country in term of revenue in European market of varicella zoster.

At what rate are Varicella Zoster Infection Treatment going to register growth in APECJ?

The APECJ market is set to exhibit a market share of over 11.0% of the global market value during the forecast period.

Which companies are key producers of Varicella zoster treatment drugs?

Novartis AG, Pfizer Inc., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd are the key producers in this market.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. Wheel of Fortune

2. Market Introduction

    2.1. Market Definition

    2.2. Market Taxonomy

3. Varicella Zoster Infection Treatment Market Opportunity Analysis 

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. Market Background

    4.1. Market Dynamics

        4.1.1. Drivers

        4.1.2. Restraints

5. Global Economic Outlook

    5.1. Disease Outlook

6. Key Inclusions

    6.1. Key Manufacture List

    6.2. Prescription Pattern

7. North America Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    7.1. Introduction

    7.2. Regional Market Trends

    7.3. Regional Scenario

    7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        7.4.1. U.S.

        7.4.2. Canada

    7.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    7.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        7.6.1. Acyclovir

        7.6.2. Valacyclovir

        7.6.3. Famciclovir

    7.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    7.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        7.8.1. Oral

        7.8.2. Topical

        7.8.3. Injectable

    7.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    7.10. Historical Market Size (US$ Mn) and Volume Trend Analysis By Distribution Channel, 2012-2021

        7.10.1. Hospital Pharmacies

        7.10.2. Retail Pharmacies

        7.10.3. Online Pharmacies

        7.10.4. Drug Stores

    7.11. Market Size (US$ Mn) and Volume Forecast By Distribution Channel, 2022-2028

    7.12. Market Attractiveness Analysis

        7.12.1. By Country

        7.12.2. By Drug Type

        7.12.3. By Route of Administration

        7.12.4. By Distribution Channel

    7.13. Key Market Participants – Intensity Mapping

8. Latin America Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    8.1. Introduction

    8.2. Regional Market Trends

    8.3. Regional Scenario

    8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        8.4.1. Brazil

        8.4.2. Mexico

        8.4.3. Rest of Latin America

    8.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    8.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        8.6.1. Acyclovir

        8.6.2. Valacyclovir

        8.6.3. Famciclovir

    8.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    8.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        8.8.1. Oral

        8.8.2. Topical

        8.8.3. Injectable

    8.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    8.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        8.10.1. Hospital Pharmacies

        8.10.2. Retail Pharmacies

        8.10.3. Online Pharmacies

        8.10.4. Drug Stores

    8.11. Market Size (US$ Mn Forecast By Distribution Channel, 2022-2028

    8.12. Market Attractiveness Analysis

        8.12.1. By Country

        8.12.2. By Drug Type

        8.12.3. By Route of Administration

        8.12.4. By Distribution Channel

    8.13. Key Market Participants – Intensity Mapping

9. Western Europe Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    9.1. Introduction

    9.2. Regional Market Trends

    9.3. Regional Scenario

    9.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        9.4.1. Germany

        9.4.2. U.K.

        9.4.3. France

        9.4.4. Italy

        9.4.5. Spain

        9.4.6. Rest of Western Europe

    9.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    9.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        9.6.1. Acyclovir

        9.6.2. Valacyclovir

        9.6.3. Famciclovir

    9.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    9.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        9.8.1. Oral

        9.8.2. Topical

        9.8.3. Injectable

    9.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    9.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        9.10.1. Hospital Pharmacies

        9.10.2. Retail Pharmacies

        9.10.3. Online Pharmacies

        9.10.4. Drug Stores

    9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    9.12. Market Attractiveness Analysis

        9.12.1. By Country

        9.12.2. By Drug Type

        9.12.3. By Route of Administration

        9.12.4. By Distribution Channel

    9.13. Key Market Participants – Intensity Mapping

10. Eastern Europe Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    10.1. Introduction

    10.2. Regional Market Trends

    10.3. Regional Scenario

    10.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        10.4.1. Russia

        10.4.2. Poland

        10.4.3. Rest of Eastern

    10.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    10.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        10.6.1. Acyclovir

        10.6.2. Valacyclovir

        10.6.3. Famciclovir

    10.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    10.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        10.8.1. Oral

        10.8.2. Topical

        10.8.3. Injectable

    10.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    10.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        10.10.1. Hospital Pharmacies

        10.10.2. Retail Pharmacies

        10.10.3. Online Pharmacies

        10.10.4. Drug Stores

    10.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    10.12. Market Attractiveness Analysis

        10.12.1. By Country

        10.12.2. By Drug Type

        10.12.3. By Route of Administration

        10.12.4. By Distribution Channel

    10.13. Key Market Participants – Intensity Mapping

11. Asia Pacific Excluding China & Japan Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    11.1. Introduction

    11.2. Regional Scenario

    11.3. Regional Market Trends

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2021

        11.4.1. India

        11.4.2. Australia and New Zealand

        11.4.3. ASEAN

        11.4.4. Rest of APECJ

    11.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    11.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        11.6.1. Acyclovir

        11.6.2. Valacyclovir

        11.6.3. Famciclovir

    11.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    11.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        11.8.1. Oral

        11.8.2. Topical

        11.8.3. Injectable

    11.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    11.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        11.10.1. Hospital Pharmacies

        11.10.2. Retail Pharmacies

        11.10.3. Online Pharmacies

        11.10.4. Drug Stores

    11.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    11.12. Market Attractiveness Analysis

        11.12.1. By Country

        11.12.2. By Drug Type

        11.12.3. By Route of Administration

        11.12.4. By Distribution Channel

    11.13. Key Market Participants – Intensity Mapping

12. China Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    12.1. Introduction

    12.2. Key Regulations

    12.3. Regional Market Trends

    12.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        12.4.1. Acyclovir

        12.4.2. Valacyclovir

        12.4.3. Famciclovir

    12.5. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    12.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        12.6.1. Oral

        12.6.2. Topical

        12.6.3. Injectable

    12.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    12.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        12.8.1. Hospital Pharmacies

        12.8.2. Retail Pharmacies

        12.8.3. Online Pharmacies

        12.8.4. Drug Stores

    12.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    12.10. Market Attractiveness Analysis

        12.10.1. By Country

        12.10.2. By Drug Type

        12.10.3. By Route of Administration

        12.10.4. By Distribution Channel

    12.11. Key Market Participants – Intensity Mapping

13. Japan Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    13.1. Introduction

    13.2. Key Regulations

    13.3. Regional Market Trends

    13.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        13.4.1. Acyclovir

        13.4.2. Valacyclovir

        13.4.3. Famciclovir

    13.5. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    13.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        13.6.1. Oral

        13.6.2. Topical

        13.6.3. Injectable

    13.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    13.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        13.8.1. Hospital Pharmacies

        13.8.2. Retail Pharmacies

        13.8.3. Online Pharmacies

        13.8.4. Drug Stores

    13.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    13.10. Market Attractiveness Analysis

        13.10.1. By Country

        13.10.2. By Drug Type

        13.10.3. By Route of Administration

        13.10.4. By Distribution Channel

    13.11. Key Market Participants – Intensity Mapping

14. Middle East & Africa Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    14.1. Introduction

    14.2. Regional Scenario

    14.3. Regional Market Trends

    14.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        14.4.1. GCC Countries

        14.4.2. North Africa

        14.4.3. South Africa

        14.4.4. Rest of MEA

    14.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    14.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        14.6.1. Acyclovir

        14.6.2. Valacyclovir

        14.6.3. Famciclovir

    14.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    14.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        14.8.1. Oral

        14.8.2. Topical

        14.8.3. Injectable

    14.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    14.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        14.10.1. Hospital Pharmacies

        14.10.2. Retail Pharmacies

        14.10.3. Online Pharmacies

        14.10.4. Drug Stores

    14.11. Market Size (US$ Mn) By Distribution Channel, 2022-2028

    14.12. Market Attractiveness Analysis

        14.12.1. By Country

        14.12.2. By Drug Type

        14.12.3. By Route of Administration

        14.12.4. By Distribution Channel

    14.13. Key Market Participants – Intensity Mapping

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        17.2.1. Teva Pharmaceutical Industries Ltd.

        17.2.2. Abbott Laboratories

        17.2.3. Sun Pharmaceuticals Industries Ltd.

        17.2.4. Mylan N.V.

        17.2.5. Pfizer Inc.

        17.2.6. GlaxoSmithKline plc.

        17.2.7. Dr. Reddy’s Laboratories, ltd.

        17.2.8. Novartis AG

        17.2.9. Valeant Pharmaceuticals International Inc.

18. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Region

    18.1. Introduction/Key Findings

    18.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021

    18.3. Market Size (US$ Mn) Forecast By Region, 2022-2028

        18.3.1. North America

        18.3.2. Latin America

        18.3.3. Western Europe

        18.3.4. Eastern Europe

        18.3.5. Asia Pacific Excluding China & Japan

        18.3.6. China

        18.3.7. Japan

        18.3.8. Middle East & Africa

    18.4. Market Attractiveness Analysis By Region

19. Global Varicella Zoster Infection Treatment Analysis 2012-2021 and Forecast 2022-2028, By Drug Type

    19.1. Introduction/Key Findings

    19.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        19.2.1. Acyclovir

        19.2.2. Valacyclovir

        19.2.3. Famciclovir

    19.3. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    19.4. Market Attractiveness Analysis By Drug Type

20. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Route of Administration

    20.1. Introduction/Key Findings

    20.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        20.2.1. Oral

        20.2.2. Topical

        20.2.3. Injectable

    20.3. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    20.4. Market Attractiveness Analysis By Route of Administration

21. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Distribution Channel

    21.1. Introduction/Key Findings

    21.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        21.2.1. Hospital Pharmacies

        21.2.2. Retail Pharmacies

        21.2.3. Online Pharmacies

        21.2.4. Drug Stores

    21.3. Market Size (US$ Mn) By Distribution Channel, 2022-2028

    21.4. Market Attractiveness Analysis By Distribution Channel

22. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    22.1. Market Value Share Analysis By All Segment

    22.2. Y-o-Y Growth Analysis By All Segment

    22.3. Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Recommendations

Healthcare

Genital Herpes Treatment Market

Published : June 2023

Healthcare

Swab and Viral Transport Medium Market

Published : March 2023

Healthcare

Rare Inflammatory Disease Treatment Market

Published : July 2022

Explore Healthcare Insights

View Reports

Varicella Zoster Infection Treatment Market